The Phase 2 trial did include lower-dose groups (1mg, 4mg, 8mg), all of which showed meaningful weight loss, just less than the 12mg group
Peptide safety awareness should precede any research protocol
Wegovy pens are available in five strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg
However, they may have additive effects on weight loss and gastrointestinal side effects, requiring careful medical supervision when used together
Fig 2: Evolving Competitive Landscape in GLP-1 Based Obesity Medications Abbreviations: AHI: Apnea Hyperpnea Index, CKD: Chronic Kidney Disease, MONW: Metabolic Obesity Normal Weight, OOP: Out-of-pocket, OSA: Obstructive Sleep Apnea, WRC: Weight- related comorbidity
Compounded Semaglutide & Tirzepatide Weight Loss Before & After Results See before-and-after photos shared by patients who have participated in InjectCos medical weight loss program in Florida